15 Key Life, Health and Annuity Regulatory Stories of 2022, So Far

Legislators and regulators could still rush out a flurry of major life, health and annuity actions, but up till now, 2022 has been more a year of fixes than of masterpieces. Aside from beginning to build the regulatory universes spawned by the No Surprises Act, which restricts the ability of health care providers to bill insured patients for out-of-network care, and the Medicare drug pricing provisions in the Inflation Reduction Act, regulators mostly fought the bad guys, tackled nagging problems, and wrestled with how to handle new products and new technologies. For a look at 14 regulatory efforts that caught our attention, ranked based on our ideas about their potential impact on retail financial professionals and their clients, see the gallery. The gallery excludes the No Surprises Act and Inflation Reduction Act start up implementation and emphasizes regulatory efforts that have a clear, direct effect, or could have a clear, direct effect, on your clients, rather than, for example, investment valuation rules. (Image: kan_chana/Shutterstock)